Efficacy of delayed-release dimethyl fumarate in multiple sclerosis patients with moderate disability: an integrated analysis of the phase 3 studies

被引:0
|
作者
Hutchinson, M. [1 ]
Zhang, A. [2 ]
Yang, M. [2 ]
Okwuokenye, M. [2 ]
Kurukulasuriya, N. C. [2 ]
Fox, R. J. [3 ]
Gold, R. [4 ]
机构
[1] St Vincents Univ Hosp, Dublin 4, Ireland
[2] Biogen Idec Inc, Cambridge, MA USA
[3] Cleveland Clin, Mellen Ctr Multiple Sclerosis Treatment & Res, Cleveland, OH 44106 USA
[4] Ruhr Univ Bochum, St Josef Hosp, Bochum, Germany
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P108
引用
收藏
页码:116 / 116
页数:1
相关论文
共 50 条
  • [1] Efficacy of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis: integrated analysis of the phase 3 trials
    Viglietta, Vissia
    Miller, David
    Bar-Or, Amit
    Phillips, J. Theodore
    Arnold, Douglas L.
    Selmaj, Krzysztof
    Kita, Mariko
    Hutchinson, Michael
    Yang, Minhua
    Zhang, Ray
    Dawson, Katherine T.
    Sheikh, Sarah I.
    Fox, Robert J.
    Gold, Ralf
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2015, 2 (02): : 103 - 118
  • [2] Efficacy of delayed-release dimethyl fumarate for relapsing-remitting multiple sclerosis using a composite measure of disability: integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Bar-Or, A.
    Gold, R.
    Fox, R. J.
    Phillips, J. T.
    Giovannoni, G.
    Kappos, L.
    Havrdova, E.
    Hutchinson, M.
    Potts, J.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 303 - 304
  • [3] Delayed-release dimethyl fumarate and disability assessed by the multiple sclerosis functional composite: integrated analysis of DEFINE and CONFIRM
    Giovannoni, G.
    Gold, R.
    Kappos, L.
    Arnold, D. L.
    Bar-Or, A.
    Kurukulasuriya, N. C.
    Yang, M.
    Sarda, S. P.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 92 - 92
  • [4] Efficacy of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing-Remitting Multiple Sclerosis Using a Composite Measure of Disability: Integrated Analysis of the Phase 3 DEFINE and CONFIRM Studies
    Phillips, J. Theodore
    Bar-Or, Amit
    Gold, Ralf
    Giovannoni, Gavin
    Fox, Robert
    Potts, James
    Soman, Teesta
    Marantz, Jing
    NEUROLOGY, 2016, 86
  • [5] Efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing-remitting multiple sclerosis using a composite measure of disability: Integrated analysis of the Phase 3 defines and confirms studies
    Phillips, J. Theodore
    Bar-Or, Amit
    Gold, Ralf
    Giovannoni, Gavin
    Fox, Robert J.
    Potts, James
    Soman, Teesta
    Marantz, Jing
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (01) : 155 - 156
  • [6] Efficacy and safety of delayed-release dimethyl fumarate in relapsing-remitting multiple sclerosis patients with cardiovascular disease: integrated analysis of the phase 3 DEFINE and CONFIRM studies
    Havrdova, E.
    Fox, R. J.
    Gold, R.
    Li, J.
    Zhang, A.
    Potts, J.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 551 - 552
  • [7] Efficacy of delayed-release dimethyl fumarate in early multiple sclerosis: post-hoc analysis of the phase 3 DEFINE and CONFIRM studies according to baseline disability
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Fox, R. J.
    Lewin, J. B.
    Zhang, A.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 263 - 264
  • [8] Efficacy of delayed-release dimethyl fumarate in newly diagnosed patients with relapsing- remitting multiple sclerosis using a composite measure of disability-Integrated analysis of the phase 3 define and confirm studies
    Phillips, J. Theodore
    Bar-Or, Amit
    Gold, Ralf
    Giovannoni, Gavin
    Fox, Robert J.
    Potts, James
    Marantz, Jing L.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : NP3 - NP4
  • [9] Safety and Efficacy of Delayed-Release Dimethyl Fumarate in Pediatric Patients With Relapsing Multiple Sclerosis (FOCUS)
    Alroughani, Raed
    Das, Rajiv
    Penner, Natasha
    Pultz, Joe
    Taylor, Catherine
    Eraly, Satish
    PEDIATRIC NEUROLOGY, 2018, 83 : 19 - 24
  • [10] Clinical efficacy of delayed-release dimethyl fumarate in Hispanic patients with relapsing-remitting multiple sclerosis: integrated analysis of define and confirm
    Hernandez, L.
    Fox, R. J.
    Gold, R.
    Phillips, J. T.
    Okwuokeny, M.
    Zhang, A.
    Rana, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E306 - E306